Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2 GBX | -42.86% | -54.29% | -75.38% |
01:50pm | Genedrive Raises GBP2 Million via Share Placing | MT |
01:12pm | Genedrive completes placing portion of GBP6 million raise | AN |
Business Summary
Number of employees: 43
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostics
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +12.24% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
63.6
%
| 0 | 75.5 % | 0 | 63.6 % | -5.41% |
Europe
29.1
%
| 0 | 20.4 % | 0 | 29.1 % | +60.00% |
United States
7.3
%
| 0 | 4.1 % | 0 | 7.3 % | +100.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Cheek
CEO | Chief Executive Officer | 57 | 10/09/23 |
Russell Shaw
DFI | Director of Finance/CFO | 45 | 06/04/22 |
Ian Gilham
CHM | Chairman | 64 | 23/11/14 |
Gino Miele
CTO | Chief Tech/Sci/R&D Officer | 54 | 30/06/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Gilham
CHM | Chairman | 64 | 23/11/14 |
Chris Yates
BRD | Director/Board Member | 50 | 21/08/18 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 08/04/18 |
Russell Shaw
DFI | Director of Finance/CFO | 45 | 06/04/22 |
James Cheek
CEO | Chief Executive Officer | 57 | 10/09/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 143,141,481 | 68,602,023 ( 47.93 %) | 0 | 47.93 % |
Company contact information
Sector
Sales per Business
Sales per region
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-74.77% | 6.27M | |
-16.09% | 18.83B | |
-40.81% | 2.92B | |
+19.34% | 1.9B | |
+2.22% | 1.71B | |
+27.00% | 1.26B | |
-9.56% | 1.04B | |
-16.29% | 961M | |
0.00% | 779M | |
-22.49% | 649M |
- Stock Market
- Equities
- EHP Stock
- Company genedrive plc